XML 129 R198.htm IDEA: XBRL DOCUMENT
v3.20.1

Appendix I - Information on Group Companies, Associates and others (Details) | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017
--- | --- | --- | ---
Diagnostic Grifols, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 55.00% | 100.00% | 100.00%
Instituto Grifols, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.998% | 99.998% | 99.998%
Proportion of indirect ownership interest | 0.002% | 0.002% | 0.002%
Grifols Worldwide Operations Spain, S.A (formerly Logister, S.A.) Merged with Grifols International in 2018 |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest |  |  | 100.00%
Laboratorios Grifols, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 98.60% | 98.60% | 98.60%
Proportion of indirect ownership interest | 1.40% | 1.40% | 1.40%
Biomat, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.90% | 99.90% | 99.90%
Proportion of indirect ownership interest | 0.10% | 0.10% | 0.10%
Grifols Engineering, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.95% | 99.95% | 99.95%
Proportion of indirect ownership interest | 0.05% | 0.05% | 0.05%
Biomat USA, Inc. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
Grifols Biologicals LLC |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
Grifols Australia Pty Ltd. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Medion Grifols Diagnostic AG |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 55.00% | 100.00% | 100.00%
Grifols Therapeutics LLC |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
Talecris Plasma Resources, Inc. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
Grifols Worldwide Operations Limited |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Progenika Biopharma, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 91.88% | 99.998% |
Proportion of indirect ownership interest | 8.12% |  | 90.23%
Asociacion I+D Progenika |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest |  | 99.998% | 90.23%
Grifols Diagnostics Solutions Inc (formerly G-C Diagnostics Corp.) |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest |  | 100.00% | 100.00%
Proportion of indirect ownership interest | 55.00% |  |
Grifols Worldwide Operations USA Inc. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
Grifols Asia Pacific Pte, Ltd |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols Movaco, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.999% | 99.999% | 99.999%
Proportion of indirect ownership interest | 0.001% | 0.001% | 0.001%
Grifols Portugal Productos Farmacuticos e Hospitalares, Lda. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 0.01% | 0.01% | 0.01%
Proportion of indirect ownership interest | 99.99% | 99.99% | 99.99%
Grifols Chile, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.00% | 99.00% | 99.00%
Grifols USA, LLC. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
Grifols Argentina, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 95.01% | 95.01% | 95.01%
Proportion of indirect ownership interest | 4.99% | 4.99% | 4.99%
Grifols s.r.o. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols (Thailand) Ltd |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 48.00% | 48.00% | 48.00%
Grifols Malaysia Sdn Bhd |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 30.00% | 30.00% | 30.00%
Grifols International, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.998% | 99.998% | 99.998%
Proportion of indirect ownership interest | 0.002% | 0.002% | 0.002%
Grifols Italia S.p.A |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols UK Ltd. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols Brasil, Lda. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Proportion of indirect ownership interest | 0.00% |  |
Grifols France, S.A.R.L. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.99% | 99.99% | 99.99%
Proportion of indirect ownership interest | 0.01% | 0.01% | 0.01%
Grifols Polska Sp.z.o.o. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Logstica Grifols, S.A. de C.V. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.99% | 99.99% | 99.99%
Proportion of indirect ownership interest | 0.01% | 0.01% | 0.01%
Grifols Mexico, S.A. de C.V. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.98% | 99.98% | 99.98%
Proportion of indirect ownership interest | 0.02% | 0.02% | 0.02%
Medion Diagnostics GmbH |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest |  | 100.00% | 100.00%
Grifols Nordic, AB |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols Colombia, Ltda |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.99% | 99.99% | 99.99%
Proportion of indirect ownership interest | 0.01% | 0.01% | 0.01%
Grifols Deutschland GmbH |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols Canada, Ltd. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
Grifols Pharmaceutical Technology (Shanghai) Co., Ltd. (formerly Grifols Pharmaceutical Consulting (Shanghai) Co., Ltd.) |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols Switzerland AG |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols (H.K.), Limited |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 55.00% | 100.00% | 100.00%
Grifols Japan K.K. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols India Healthcare Private Ltd |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.984% | 99.984% | 99.984%
Proportion of indirect ownership interest | 0.016% | 0.016% | 0.016%
Grifols Diagnostics Equipment Taiwan Limited |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Grifols Viajes, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.90% | 99.90% | 99.90%
Proportion of indirect ownership interest | 0.10% | 0.10% | 0.10%
Squadron Reinsurance Designated Activity Company (formerly Squadron Reinsurance Ltd.) |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
Grifols Shared Services North America, Inc. (formerly Grifols Inc.) |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Gripdan Invest, S.L |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 100.00% | 100.00% | 100.00%
Gri-Cel, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest |  | 0.001% | 0.001%
Proportion of indirect ownership interest |  | 99.999% | 99.999%
Araclon Biotech, S.L. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 75.10% | 73.22% | 73.22%
VCN Bioscience, S.L. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 81.34% | 81.34% | 81.34%
Grifols Innovation and New Technologies Limited |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
PBS Acquisition Corp. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest |  | 100.00% | 100.00%
Kiro Grifols S. L (formerly Kiro Robotics S.L) |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 90.00% | 90.00% | 90.00%
Chiquito Acquisition Corp. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% | 100.00% | 100.00%
Aiges Minerals de Vilajuiga, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest | 99.99% | 100.00% |
Proportion of indirect ownership interest | 0.01% |  |
Goetech LLC (D/B/A Medkeeper) |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 54.76% | 54.76% |
Interstate Blood Bank, Inc |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 100.00% |  |
Aradigm Corporation |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 35.13% | 35.13% | 35.13%
TiGenix N.V. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest |  |  | 14.18%
Mecwins, S.L. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 24.99% | 24.99% | 8.42%
Alkahest, Inc. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 47.58% | 47.58% | 47.58%
Albajuna Therapeutics, S.L |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 49.00% | 30.00% | 30.00%
Interstate Blood Bank, Inc. (USA) |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest |  | 49.19% | 49.19%
Bio Blood Components Inc. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest |  | 48.972% | 48.972%
Plasma Biological Services, LLC. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest |  | 48.90% | 48.90%
Singulex, Inc. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 19.33% | 19.33% | 19.33%
Aigues Minerals de Vilajuiga S. A. |  |  |
Information on group companies associates and others |  |  |
Proportion of direct ownership interest |  |  | 50.00%
Access Biologicals, LLC |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 49.00% | 49.00% | 49.00%
Access Biologicals IC - DISC, Inc. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 49.00% | 49.00% | 49.00%
Access Cell Culture, LLC. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 49.00% | 49.00% | 49.00%
Access Manufacturing, LLC. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest |  | 49.00% | 49.00%
Access Plasma, LLC. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 49.00% | 49.00% | 49.00%
GigaGen Inc. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 43.96% | 43.96% | 43.96%
Plasmavita HealthCare |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 50.00% | 50.00% |
Medcom Advance, S.A. |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 45.00% |  |
Plasmavita Healthcare II GmbH |  |  |
Information on group companies associates and others |  |  |
Proportion of indirect ownership interest | 50.00% |  |

X
- Definition Line item represents information on group companies associates and others. + References No definition available. + Details
Name: | grfs_DisclosureOfInformationOnGroupCompaniesAssociatesAndOthersLineItems
Namespace Prefix: | grfs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The proportion of direct ownership interest. + References No definition available. + Details
Name: | grfs_ProportionOfDirectOwnershipInterest
Namespace Prefix: | grfs_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The proportion of indirect ownership interest. + References No definition available. + Details
Name: | grfs_ProportionOfIndirectOwnershipInterest
Namespace Prefix: | grfs_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_DiagnosticGrifolsS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_InstitutoGrifolsS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsWorldwideOperationsSpainS.aMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_LaboratoriosGrifolsS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_BiomatS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsEngineeringS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_BiomatUsaIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsBiologicalsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsAustraliaPrivateLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_MedionGrifolsDiagnosticAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsTherapeuticsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_TalecrisPlasmaResourcesIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsWorldwideOperationsLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_ProgenikaBiopharmaS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AsociacionIDProgenikaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsDiagnosticsSolutionsIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsWorldwideOperationsUsaIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsAsiaPacificPrivateLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsMovacoS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsPortugalProductosFarmaceuticosEHospitalaresLda.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsChileS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsUsaLimitedLiabilityCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsArgentinaS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsS.r.o.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsThailandLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsMalaysiaSdnBhdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsInternationalS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsItaliaS.p.aMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsUkLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsBrasilLda.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsFranceS.a.r.l.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsPolskaSp.z.o.o.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_LogsticaGrifolsS.a.DeC.v.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsMexicoS.a.DeC.v.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_MedionDiagnosticsGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsNordicAbMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsColombiaLimitedLiabilityCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsDeutschlandGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsCanadaLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsPharmaceuticalTechnologyShanghaiCo.LimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsSwitzerlandAgMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsH.k.LimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsJapanK.k.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsIndiaHealthcarePrivateLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsDiagnosticsEquipmentTaiwanLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsViajesS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_SquadronReinsuranceDesignatedActivityCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsSharedServicesNorthAmericaIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GripdanInvestS.lMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GriCelS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AraclonBiotechS.l.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_VcnBioscienceS.l.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GrifolsInnovationAndNewTechnologiesLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_PbsAcquisitionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_KiroGrifolsS.LMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_ChiquitoAcquisitionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AigesMineralsDeVilajuigaS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GoetechLlcDBMedkeeperMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_InterstateBloodBankIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AradigmCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_TigenixN.v.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_MecwinsS.l.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AlkahestIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AlbajunaTherapeuticsS.lMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_InterstateBloodBankIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_BioBloodComponentsIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_PlasmaBiologicalServicesLimitedLiabilityCompanyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_SingulexIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AiguesMineralsDeVilajuigaS.A.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AccessBiologicalLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AccessBiologicalsICDISCInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AccessCellCultureLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AccessManufacturingLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_AccessPlasmaLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_GigaGenIncorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_PlasmavitaHealthcareGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_MedcomAdvanceS.aMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CounterpartiesAxis=grfs_PlasmavitaHealthcareTwoGmbhMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |